Zentek (CVE:ZEN) Stock Price Down 7.8% – Should You Sell?

Zentek Ltd. (CVE:ZEN)’s share price fell 7.8% during trading on Monday . The stock traded as low as C$0.61 and last traded at C$0.71. Approximately 258,275 shares were traded during trading, an increase of 69% from the average daily volume of 153,260 shares. The stock had previously closed at C$0.77.

Zentek Price Performance

The company has a market capitalization of C$92.43 million, a P/E ratio of -7.53 and a beta of 0.72. The business’s 50-day simple moving average is C$0.76 and its 200 day simple moving average is C$0.78. The company has a current ratio of 4.65, a quick ratio of 7.59 and a debt-to-equity ratio of 7.62.

Zentek Company Profile

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada.